The Split Virus Influenza Vaccine rapidly activates immune cells through Fcγ receptors.

Single-cell systems-level analysis of human Toll-like receptor activation defines a chemokine signature in patients with systemic lupus erythematosus. J Allergy Clin Immunol (2015) 0.88

New approaches to understanding the immune response to vaccination and infection. Vaccine (2015) 0.82

Paradoxical changes in innate immunity in aging: recent progress and new directions. J Leukoc Biol (2015) 0.82

Heparin reduces nonspecific eosinophil staining artifacts in mass cytometry experiments. Cytometry A (2016) 0.77

Polychromatic flow cytometry in evaluating rheumatic disease patients. Arthritis Res Ther (2015) 0.76

Role of Immune Aging in Susceptibility to West Nile Virus. Methods Mol Biol (2016) 0.75

An adjuvant-modulated vaccine response in human whole blood. Hum Vaccin Immunother (2017) 0.75

Single-cell mass cytometry of differential immune and drug responses across a human hematopoietic continuum. Science (2011) 15.45

Monocyte chemoattractant protein-1 (MCP-1): an overview. J Interferon Cytokine Res (2009) 7.83

Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J Immunol (2002) 7.60

Human CD14dim monocytes patrol and sense nucleic acids and viruses via TLR7 and TLR8 receptors. Immunity (2010) 5.43

Cytometry by time-of-flight shows combinatorial cytokine expression and virus-specific cell niches within a continuum of CD8+ T cell phenotypes. Immunity (2012) 5.26

Ribosomal protein S6 phosphorylation: from protein synthesis to cell size. Trends Biochem Sci (2006) 5.11

Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. J Exp Med (2006) 4.23

The effect of passively administered antibody on antibody synthesis. J Exp Med (1967) 3.31

Influence of prior influenza vaccination on antibody and B-cell responses. PLoS One (2008) 2.83

Age-associated decrease in TLR function in primary human dendritic cells predicts influenza vaccine response. J Immunol (2010) 2.63

Innate immunity against vaccinia virus is mediated by TLR2 and requires TLR-independent production of IFN-beta. Blood (2006) 2.35

Vaccines for seasonal and pandemic influenza. J Infect Dis (2006) 2.14

Systems scale interactive exploration reveals quantitative and qualitative differences in response to influenza and pneumococcal vaccines. Immunity (2013) 2.08

Seroprotection rate, mean fold increase, seroconversion rate: which parameter adequately expresses seroresponse to influenza vaccination? Virus Res (2004) 1.90

The multiple facets of mTOR in immunity. Trends Immunol (2009) 1.89

Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by Toll-like receptor signalling. PLoS Pathog (2008) 1.83

Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants. Vaccine (2003) 1.76

Apoptosis and other immune biomarkers predict influenza vaccine responsiveness. Mol Syst Biol (2013) 1.75

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial. Lancet (2003) 1.75

Fc receptor-targeted therapies for the treatment of inflammation, cancer and beyond. Nat Rev Drug Discov (2012) 1.62

Seasonal influenza vaccine efficacy and its determinants in children and non-elderly adults: a systematic review with meta-analyses of controlled trials. Vaccine (2012) 1.51

Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes. Sci Transl Med (2010) 1.46

Inflammasomes as mediators of immunity against influenza virus. Trends Immunol (2010) 1.35

Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs. Influenza Other Respir Viruses (2008) 1.33

Antibody-mediated regulation of the immune response. Scand J Immunol (2006) 1.32

Trials of influenza A/New Jersey/76 virus vaccine in normal children: an overview of age-related antigenicity and reactogenicity. J Infect Dis (1977) 1.26

Toll-like receptor-mediated activation of neutrophils by influenza A virus. Blood (2008) 1.24

Vaccines for pandemic influenza. The history of our current vaccines, their limitations and the requirements to deal with a pandemic threat. Ann Acad Med Singapore (2008) 1.14

Passively acquired antibodies suppress humoral but not cell-mediated immunity in mice immunized with live attenuated respiratory syncytial virus vaccines. J Immunol (2001) 1.11

How antibodies act as natural adjuvants. Immunol Lett (2005) 1.09

Mechanism for increased immunogenicity of vaccines that form in vivo immune complexes with the natural anti-Gal antibody. Vaccine (2009) 1.06

Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens. Infect Immun (2005) 1.05

TLR7 recognition is dispensable for influenza virus A infection but important for the induction of hemagglutinin-specific antibodies in response to the 2009 pandemic split vaccine in mice. J Virol (2012) 0.97

Insights into the regulatory mechanism controlling the inhibition of vaccine-induced seroconversion by maternal antibodies. Blood (2011) 0.96

Conversion of a capture ELISA to a Luminex xMAP assay using a multiplex antibody screening method. J Vis Exp (2012) 0.94

Activation of Fc gamma RI on monocytes triggers differentiation into immature dendritic cells that induce autoreactive T cell responses. J Immunol (2009) 0.90

Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon-α-dependent apoptosis. Vaccine (2013) 0.82